Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

aTYR PHARMA INC (LIFE) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/19/2023 4 Zaknoen Sara (Director) has filed a Form 4 on aTYR PHARMA INC
Txns: Granted 12,000 options to buy @ $2.52, valued at $30.2k
05/19/2023 4 SCHIMMEL PAUL (Director) has filed a Form 4 on aTYR PHARMA INC
Txns: Granted 12,000 options to buy @ $2.52, valued at $30.2k
05/19/2023 4 Lucas Svetlana (Director) has filed a Form 4 on aTYR PHARMA INC
Txns: Granted 12,000 options to buy @ $2.52, valued at $30.2k
05/19/2023 4 Gross Jane A (Director) has filed a Form 4 on aTYR PHARMA INC
Txns: Granted 12,000 options to buy @ $2.52, valued at $30.2k
05/19/2023 4 COUGHLIN TIMOTHY (Director) has filed a Form 4 on aTYR PHARMA INC
Txns: Gifted 6,000 shares @ $0
Gifted 6,000 shares @ $0
Granted 12,000 options to buy @ $2.52, valued at $30.2k
05/19/2023 4 CLARKE JOHN K (Director) has filed a Form 4 on aTYR PHARMA INC
Txns: Granted 12,000 options to buy @ $2.52, valued at $30.2k
05/11/2023 4 SCHIMMEL PAUL (Director) has filed a Form 4 on aTYR PHARMA INC
Txns: Bought 200,000 shares @ $2.25, valued at $450k
04/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/28/2023 4 CLARKE JOHN K (Director) has filed a Form 4 on aTYR PHARMA INC
Txns: Exercised 6,000 restricted stock units @ $0
04/28/2023 4 SCHIMMEL PAUL (Director) has filed a Form 4 on aTYR PHARMA INC
Txns: Exercised 6,000 restricted stock units @ $0
04/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/21/2023 4 Shukla Sanjay (President and CEO) has filed a Form 4 on aTYR PHARMA INC
Txns: Granted 336,096 options to buy @ $2.195, valued at $737.7k
02/21/2023 4 Broadfoot Jill Marie (CFO) has filed a Form 4 on aTYR PHARMA INC
Txns: Granted 84,023 options to buy @ $2.195, valued at $184.4k
02/21/2023 4 DENYES NANCY (General Counsel) has filed a Form 4 on aTYR PHARMA INC
Txns: Granted 84,023 options to buy @ $2.195, valued at $184.4k
02/06/2023 4 DENYES NANCY (General Counsel) has filed a Form 4 on aTYR PHARMA INC
Txns: Exercised 2,688 restricted stock units @ $0
02/06/2023 4 Broadfoot Jill Marie (CFO) has filed a Form 4 on aTYR PHARMA INC
Txns: Sold 1,566 shares @ $2.36, valued at $3.7k
Exercised 3,750 restricted stock units @ $0
02/06/2023 4 Shukla Sanjay (President and CEO) has filed a Form 4 on aTYR PHARMA INC
Txns: Exercised 10,375 restricted stock units @ $0
11/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/06/2022 4 Shukla Sanjay (President and CEO) has filed a Form 4 on aTYR PHARMA INC
Txns: Bought 15,000 shares @ $2.8776, valued at $43.2k
05/26/2022 4 DENYES NANCY (General Counsel) has filed a Form 4 on aTYR PHARMA INC
Txns: Granted 88,097 options to buy @ $2.81, valued at $247.6k
05/26/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/26/2022 4 Shukla Sanjay (President and CEO) has filed a Form 4 on aTYR PHARMA INC
Txns: Granted 516,280 options to buy @ $2.81, valued at $1.5M
04/28/2022 4 Zaknoen Sara (Director) has filed a Form 4 on aTYR PHARMA INC
Txns: Granted 6,000 restricted stock units @ $0
04/28/2022 4 SCHIMMEL PAUL (Director) has filed a Form 4 on aTYR PHARMA INC
Txns: Granted 6,000 restricted stock units @ $0
04/28/2022 4 Lucas Svetlana (Director) has filed a Form 4 on aTYR PHARMA INC
Txns: Granted 6,000 restricted stock units @ $0
04/28/2022 4 Gross Jane A (Director) has filed a Form 4 on aTYR PHARMA INC
Txns: Granted 6,000 restricted stock units @ $0
04/28/2022 4 COUGHLIN TIMOTHY (Director) has filed a Form 4 on aTYR PHARMA INC
Txns: Granted 6,000 restricted stock units @ $0
04/28/2022 4 CLARKE JOHN K (Director) has filed a Form 4 on aTYR PHARMA INC
Txns: Granted 6,000 restricted stock units @ $0
02/07/2022 4 DENYES NANCY (General Counsel) has filed a Form 4 on aTYR PHARMA INC
Txns: Granted 21,500 options to buy @ $5.52, valued at $118.7k
Granted 10,750 restricted stock units @ $0
02/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/07/2022 4 Shukla Sanjay (President and CEO) has filed a Form 4 on aTYR PHARMA INC
Txns: Granted 83,000 options to buy @ $5.52, valued at $458.2k
Granted 41,500 restricted stock units @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy